Literature DB >> 17635138

Phenotypic classification of mutants: a tool for understanding ligand binding and activation of muscarinic acetylcholine receptors.

E C Hulme1, M S Bee, J A Goodwin.   

Abstract

GPCRs (G-protein-coupled receptors) such as the M(1) muscarinic receptor have so far proved recalcitrant to direct structure determination. Nevertheless systematic mutagenesis, particularly alanine scanning, has advanced our understanding of their structure-function relationships. GPCRs exhibit multiple conformational states with different affinities for and abilities to activate their cognate G-proteins. Ligand binding alters these conformational equilibria, thus promoting or inhibiting signalling. Alanine-scanning mutagenesis probes the relative contributions of a particular amino acid side chain to the stability of the ground and activated states of the receptor and its complexes. These determine the phenotype of the mutant receptor. Classification of the phenotypes suggests functional roles for particular amino acid side chains, allowing us to group them accordingly. From a rhodopsin-based homology model of the M(1) mAChR, a coherent view emerges of how these clusters of residues function in ligand anchoring, transduction of binding energy, global structural stabilization and selective stabilization of the ground state or the activated state of the receptor. We can identify differences in ligand-binding modes, and suggest inter- and intra-molecular interactions that are weakened or broken, or formed or intensified during acetylcholine-induced activation. In due course, we may be able to extend these insights to activation by unconventional agonists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17635138     DOI: 10.1042/BST0350742

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  6 in total

1.  Role of conserved glycine in zinc-dependent medium chain dehydrogenase/reductase superfamily.

Authors:  Manish Kumar Tiwari; Raushan Kumar Singh; Ranjitha Singh; Marimuthu Jeya; Huimin Zhao; Jung-Kul Lee
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

2.  Functional and structural roles of residues in the third extramembrane segment of adrenal cytochrome b561.

Authors:  Wen Liu; Giordano F Z da Silva; Gang Wu; Graham Palmer; Ah-Lim Tsai; Richard J Kulmacz
Journal:  Biochemistry       Date:  2011-03-25       Impact factor: 3.162

3.  Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors.

Authors:  Guillaume Lebon; Christopher J Langmead; Ben G Tehan; Edward C Hulme
Journal:  Mol Pharmacol       Date:  2008-11-11       Impact factor: 4.436

4.  Helix 8 of the M1 muscarinic acetylcholine receptor: scanning mutagenesis delineates a G protein recognition site.

Authors:  Robert G Kaye; José W Saldanha; Zhi-Liang Lu; Edward C Hulme
Journal:  Mol Pharmacol       Date:  2011-01-19       Impact factor: 4.436

5.  Molecular modeling of the M3 acetylcholine muscarinic receptor and its binding site.

Authors:  Marlet Martinez-Archundia; Arnau Cordomi; Pere Garriga; Juan J Perez
Journal:  J Biomed Biotechnol       Date:  2012-02-27

6.  In silico saturation mutagenesis and docking screening for the analysis of protein-ligand interaction: the Endothelial Protein C Receptor case study.

Authors:  Federica Chiappori; Pasqualina D'Ursi; Ivan Merelli; Luciano Milanesi; Ermanna Rovida
Journal:  BMC Bioinformatics       Date:  2009-10-15       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.